Last reviewed · How we verify

Cimifuga Racemosa

Federal University of Minas Gerais · FDA-approved active Small molecule

Cimicifuga racemosa (black cohosh) is a herbal extract that modulates estrogen-like activity and may reduce vasomotor symptoms through serotonergic and other neuroendocrine pathways.

Cimicifuga racemosa (black cohosh) is a herbal extract that modulates estrogen-like activity and may reduce vasomotor symptoms through serotonergic and other neuroendocrine pathways. Used for Menopausal vasomotor symptoms (hot flashes, night sweats), Menopausal mood and sleep disturbances.

At a glance

Generic nameCimifuga Racemosa
Also known asClifemin, Acteia
SponsorFederal University of Minas Gerais
Drug classHerbal extract / phytoestrogen
ModalitySmall molecule
Therapeutic areaWomen's Health / Menopause
PhaseFDA-approved

Mechanism of action

The rhizome of Cimicifuga racemosa contains phytoestrogens and other bioactive compounds that interact with estrogen receptors and serotonin pathways. It is traditionally used to alleviate menopausal symptoms such as hot flashes and night sweats, though the exact molecular mechanisms remain incompletely characterized. The extract may also have anti-inflammatory and antioxidant properties.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: